tirzepatide press release Breaking FDA Approves Tirzepatide, A Potential

We need better evidence on how these medications work and what to do after stopping, such as how to transition care and what kinds of lifestyle and psychological support help to maintain benefits. The new research comes at a time when access to, and interest in, weight-loss medications is rapidly expanding across the globe

in Cardiology/Journal Scans/2025/07/10/09/09/SURMOUNT 5 Mamas, M.A., Bays, H., et al

Studies show that semaglutide and tirzepatide are better at promoting weight loss than other anti-obesity medications (3)

Dose-response relationships for vitamin D remain poorly characterized for most health outcomes